NeuroLight, Inc., a neuromodulation company first to develop technology for transplanting brain states™, hires Dr. Nevine El-leithy as the Chief Scientific Officer (CSO). Former Research Director and Professor of Deep Brain Neurotech at the University of Maryland, Dr. El-leithy will lead NeuroLight’s R&D focused on

NeuroLight, Inc., a neuromodulation company first to develop technology for transplanting mental states™, awarded grant from the U.S. National Science Foundation (NSF)

Neuroenhancement Lab, Inc., a neuromodulation company first to develop technology for transplanting mental states™ from one person to another, rebrands itself as NeuroLight.

Suffern, N.Y., February 25, 2018—Neuroenhancement Lab, Inc., a neuromodulation company headquartered in Suffern, NY, announced today that Parisa Khosropour joined its Advisory Board. As a pioneer in neuromodulation, Neuroenhancement Lab is the first company to develop technology for transplanting mental state™ from one person to